You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR DANOCRINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for DANOCRINE

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01667263 ↗	The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia	Completed	Beijing Hospital	Phase 2	2012-06-01	Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗	The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia	Completed	Beijing Municipal Science & Technology Commission	Phase 2	2012-06-01	Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗	The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia	Completed	Beijing Tongren Hospital	Phase 2	2012-06-01	Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗	The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia	Completed	Navy General Hospital, Beijing	Phase 2	2012-06-01	Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗	The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia	Completed	Qilu Hospital of Shandong University	Phase 2	2012-06-01	Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for DANOCRINE

Condition Name

Chart
Table

Condition Name for DANOCRINE
Intervention	Trials
Immune Thrombocytopenia	3
Primary Myelofibrosis	2
Post-essential Thrombocythemia Myelofibrosis	1
Post-polycythemia Vera Myelofibrosis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for DANOCRINE
Intervention	Trials
Thrombocytopenia	4
Purpura, Thrombocytopenic, Idiopathic	4
Primary Myelofibrosis	2
Hemostatic Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for DANOCRINE

Trials by Country

Map
Table

Trials by Country for DANOCRINE
Location	Trials
United States	14
France	11
Poland	9
Hungary	8
Italy	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for DANOCRINE
Location	Trials
New York	2
Arizona	2
Texas	1
Pennsylvania	1
Ohio	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for DANOCRINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for DANOCRINE
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	4
Phase 1/Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for DANOCRINE
Clinical Trial Phase	Trials
Recruiting	2
Completed	2
Not yet recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for DANOCRINE

Sponsor Name

Chart
Table

Sponsor Name for DANOCRINE
Sponsor	Trials
Peking University People's Hospital	4
National Cancer Institute (NCI)	1
Mayo Clinic	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for DANOCRINE
Sponsor	Trials
Other	10
Industry	1
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.